CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CEACAM5 | Carcinoembryonic antigen-related cell adhesion molecule 5 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
CKAP4 | Cytoskeleton-associated protein 4 | Cytoskeleton related proteins Predicted membrane proteins
| | | | | Expressed in all |
CLDN16 | Claudin 16 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CMTM5 | CKLF-like MARVEL transmembrane domain containing 5 | Predicted membrane proteins
| | | | | Tissue enriched |
COLEC12 | Collectin sub-family member 12 | Predicted membrane proteins
| | | | | Tissue enhanced |
COMT | Catechol-O-methyltransferase | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
COX4I1 | Cytochrome c oxidase subunit IV isoform 1 | Mitochondrial proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
CPT1A | Carnitine palmitoyltransferase 1A (liver) | Disease related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CS | Citrate synthase | Citric acid cycle related proteins Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
CYBA | Cytochrome b-245, alpha polypeptide | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
DAG1 | Dystroglycan 1 (dystrophin-associated glycoprotein 1) | Cytoskeleton related proteins Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DCT | Dopachrome tautomerase | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
DDOST | Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit (non-catalytic) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DIABLO | Diablo, IAP-binding mitochondrial protein | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
DNPEP | Aspartyl aminopeptidase | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
DSG2 | Desmoglein 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ELTD1 | EGF, latrophilin and seven transmembrane domain containing 1 | G-protein coupled receptors Plasma proteins Predicted membrane proteins Transporters
| | | | | Mixed |
EMD | Emerin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ENDOD1 | Endonuclease domain containing 1 | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENTPD4 | Ectonucleoside triphosphate diphosphohydrolase 4 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
F11R | F11 receptor | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Group enriched |
FMNL1 | Formin-like 1 | Predicted membrane proteins
| | | | | Expressed in all |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
FUT8 | Fucosyltransferase 8 (alpha (1,6) fucosyltransferase) | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
GCLC | Glutamate-cysteine ligase, catalytic subunit | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
GJA1 | Gap junction protein, alpha 1, 43kDa | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Mixed |
GOLGA5 | Golgin A5 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
HLA-DRA | Major histocompatibility complex, class II, DR alpha | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HMGN1 | High mobility group nucleosome binding domain 1 | Predicted membrane proteins
| | | | | Expressed in all |
HTATIP2 | HIV-1 Tat interactive protein 2, 30kDa | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ICAM3 | Intercellular adhesion molecule 3 | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
IFITM1 | Interferon induced transmembrane protein 1 | CD markers Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | Cancer-related genes Disease related genes Predicted membrane proteins Transcription factors
| | | | | Tissue enhanced |
ITGA3 | Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ITGA5 | Integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGA6 | Integrin, alpha 6 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ITGAV | Integrin, alpha V | Cancer-related genes CD markers FDA approved drug targets Predicted membrane proteins
| | | | | Expressed in all |
ITGB1 | Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | Cancer-related genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ITGB4 | Integrin, beta 4 | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
JTB | Jumping translocation breakpoint | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
KIT | V-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Mixed |
KTN1 | Kinectin 1 (kinesin receptor) | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |